• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于加权基因共表达网络分析的胃癌预后及免疫浸润预测模型

A Weighted Gene Co-Expression Network Analysis-Derived Prognostic Model for Predicting Prognosis and Immune Infiltration in Gastric Cancer.

作者信息

Chen Qingchuan, Tan Yuen, Zhang Chao, Zhang Zhe, Pan Siwei, An Wen, Xu Huimian

机构信息

Department of Surgical Oncology, The First Affiliated Hospital of China Medical University, Shenyang, China.

出版信息

Front Oncol. 2021 Feb 25;11:554779. doi: 10.3389/fonc.2021.554779. eCollection 2021.

DOI:10.3389/fonc.2021.554779
PMID:33718128
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7947930/
Abstract

BACKGROUND

Gastric cancer (GC) is a major public health problem worldwide. In recent decades, the treatment of gastric cancer has improved greatly, but basic research and clinical application of gastric cancer remain challenges due to the high heterogeneity. Here, we provide new insights for identifying prognostic models of GC.

METHODS

We obtained the gene expression profiles of GSE62254 containing 300 samples for training. GSE15459 and TCGA-STAD for validation, which contain 200 and 375 samples, respectively. Weighted gene co-expression network analysis (WGCNA) was used to identify gene modules. We performed Lasso regression and Cox regression analyses to identify the most significant five genes to develop a novel prognostic model. And we selected two representative genes within the model for immunohistochemistry staining with 105 GC specimens from our hospital to verify the prediction efficiency. Moreover, we estimated the correlation coefficient between our model and immune infiltration using the CIBERSORT algorithm. The data from GSE15459 and TCGA cohort validated the robustness and predictive accuracy of this prognostic model.

RESULTS

Of the 12 gene modules identified, 1,198 green-yellow module genes were selected for further analysis. Multivariate Cox analysis was performed on genes from univariate Cox regression and Lasso regression analysis using the Cox proportional hazards regression model. Finally, we constructed a five gene prognostic model: Risk Score = [(-0.7547) * Expression ()] + [(-0.8272) * Expression ()] + [1.09 * Expression ()] + [0.5174 * Expression ()] + [1.66 * Expression ()]. The prognosis of samples in the high-risk group was significantly poorer than that of samples in the low-risk group (p = 6.503e-11). The risk model was also regarded as an independent predictor of prognosis (HR, 1.678, p < 0.001). The observed correlation with immune cells suggested that this risk model could potentially predict immune infiltration.

CONCLUSION

This study identified a potential risk model for prognosis and immune infiltration prediction in GC using WGCNA and Cox regression analysis.

摘要

背景

胃癌(GC)是全球主要的公共卫生问题。近几十年来,胃癌的治疗有了很大改善,但由于高度异质性,胃癌的基础研究和临床应用仍然面临挑战。在此,我们为识别胃癌的预后模型提供了新的见解。

方法

我们获取了包含300个样本的GSE62254基因表达谱用于训练。分别获取包含200个样本的GSE15459和包含375个样本的TCGA-STAD用于验证。使用加权基因共表达网络分析(WGCNA)来识别基因模块。我们进行了Lasso回归和Cox回归分析,以识别最显著的五个基因来构建一个新的预后模型。并且我们从模型中选择两个代表性基因,对我院105例胃癌标本进行免疫组织化学染色,以验证预测效率。此外,我们使用CIBERSORT算法估计了我们的模型与免疫浸润之间的相关系数。来自GSE15459和TCGA队列的数据验证了该预后模型的稳健性和预测准确性。

结果

在识别出的12个基因模块中,选择了1198个绿黄色模块基因进行进一步分析。使用Cox比例风险回归模型对单变量Cox回归和Lasso回归分析中的基因进行多变量Cox分析。最后,我们构建了一个五基因预后模型:风险评分 = [(-0.7547)*表达()] + [(-0.8272)*表达()] + [1.09 *表达()] + [0.5174 *表达()] + [1.66 *表达()]。高风险组样本的预后明显差于低风险组样本(p = 6.503e-11)。风险模型也被视为预后的独立预测因子(HR,1.678,p < 0.001)。观察到的与免疫细胞的相关性表明该风险模型可能潜在地预测免疫浸润。

结论

本研究使用WGCNA和Cox回归分析识别了一种用于胃癌预后和免疫浸润预测的潜在风险模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/7947930/0d9c2fc67735/fonc-11-554779-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/7947930/f75334ae0175/fonc-11-554779-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/7947930/7b17c5e64a6a/fonc-11-554779-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/7947930/d8e990a68357/fonc-11-554779-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/7947930/34b2e20ea86a/fonc-11-554779-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/7947930/69603523a251/fonc-11-554779-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/7947930/1ce0ebfcea94/fonc-11-554779-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/7947930/e05355bcceda/fonc-11-554779-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/7947930/8fd011aba29a/fonc-11-554779-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/7947930/bd6916fef18e/fonc-11-554779-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/7947930/baf009841492/fonc-11-554779-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/7947930/05f7ad9911d9/fonc-11-554779-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/7947930/0d9c2fc67735/fonc-11-554779-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/7947930/f75334ae0175/fonc-11-554779-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/7947930/7b17c5e64a6a/fonc-11-554779-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/7947930/d8e990a68357/fonc-11-554779-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/7947930/34b2e20ea86a/fonc-11-554779-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/7947930/69603523a251/fonc-11-554779-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/7947930/1ce0ebfcea94/fonc-11-554779-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/7947930/e05355bcceda/fonc-11-554779-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/7947930/8fd011aba29a/fonc-11-554779-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/7947930/bd6916fef18e/fonc-11-554779-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/7947930/baf009841492/fonc-11-554779-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/7947930/05f7ad9911d9/fonc-11-554779-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd36/7947930/0d9c2fc67735/fonc-11-554779-g012.jpg

相似文献

1
A Weighted Gene Co-Expression Network Analysis-Derived Prognostic Model for Predicting Prognosis and Immune Infiltration in Gastric Cancer.一种基于加权基因共表达网络分析的胃癌预后及免疫浸润预测模型
Front Oncol. 2021 Feb 25;11:554779. doi: 10.3389/fonc.2021.554779. eCollection 2021.
2
A novel signature based on CeRNA and immune status predicts prognostic risk and drug sensitivity in gastric cancer patients.基于 ceRNA 和免疫状态的新型标志物可预测胃癌患者的预后风险和药物敏感性。
Front Immunol. 2022 Nov 22;13:951135. doi: 10.3389/fimmu.2022.951135. eCollection 2022.
3
Construction and validation of a novel coagulation-related 7-gene prognostic signature for gastric cancer.一种新型胃癌凝血相关7基因预后标志物的构建与验证
Front Genet. 2022 Aug 29;13:957655. doi: 10.3389/fgene.2022.957655. eCollection 2022.
4
Integrated analysis of 1804 samples of six centers to construct and validate a robust immune-related prognostic signature associated with stromal cell abundance in tumor microenvironment for gastric cancer.对六个中心的 1804 个样本进行综合分析,构建和验证一个与胃癌肿瘤微环境中基质细胞丰度相关的稳健免疫相关预后标志物。
World J Surg Oncol. 2022 Jan 5;20(1):4. doi: 10.1186/s12957-021-02485-y.
5
Identification of Prognostic Genes in Neuroblastoma in Children by Weighted Gene Coexpression Network Analysis.通过加权基因共表达网络分析鉴定儿童神经母细胞瘤中的预后基因
Biochem Res Int. 2021 Jul 27;2021:9987990. doi: 10.1155/2021/9987990. eCollection 2021.
6
A novel immune-related lncRNA pair signature for prognostic prediction and immune response evaluation in gastric cancer: a bioinformatics and biological validation study.一种用于胃癌预后预测和免疫反应评估的新型免疫相关lncRNA对特征:一项生物信息学和生物学验证研究
Cancer Cell Int. 2022 Feb 10;22(1):69. doi: 10.1186/s12935-022-02493-2.
7
Metabolism reprogramming signature associated with stromal cells abundance in tumor microenvironment improve prognostic risk classification for gastric cancer.与肿瘤微环境中基质细胞丰度相关的代谢重编程特征可改善胃癌的预后风险分类。
BMC Gastroenterol. 2022 Jul 30;22(1):364. doi: 10.1186/s12876-022-02451-2.
8
Identification of a novel 10 immune-related genes signature as a prognostic biomarker panel for gastric cancer.鉴定一个新的 10 个免疫相关基因特征作为胃癌的预后生物标志物panel。
Cancer Med. 2021 Sep;10(18):6546-6560. doi: 10.1002/cam4.4180. Epub 2021 Aug 12.
9
Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.利用网络分析鉴定甲状腺乳头状癌免疫浸润和预后中的铁死亡基因
BMC Genomics. 2021 Jul 27;22(1):576. doi: 10.1186/s12864-021-07895-6.
10
Prognostic value and risk model construction of hypoxic stress-related features in predicting gastric cancer.缺氧应激相关特征在预测胃癌中的预后价值及风险模型构建
Am J Transl Res. 2022 Dec 15;14(12):8599-8610. eCollection 2022.

引用本文的文献

1
Exploring the heterogeneity of osteosarcoma cell characteristics and metabolic states and their association with clinical prognosis.探索骨肉瘤细胞特征和代谢状态的异质性及其与临床预后的关联。
Front Immunol. 2024 Dec 6;15:1507476. doi: 10.3389/fimmu.2024.1507476. eCollection 2024.
2
A novel prognostic 6-gene signature for osteoporosis.一种用于骨质疏松症的新型预后 6 基因标志物。
Front Endocrinol (Lausanne). 2022 Sep 21;13:968397. doi: 10.3389/fendo.2022.968397. eCollection 2022.
3
Molecular Pathways and Key Genes Associated With Breast Width and Protein Content in White Striping and Wooden Breast Chicken Pectoral Muscle.

本文引用的文献

1
LINC01235-TWIST2 feedback loop facilitates epithelial-mesenchymal transition in gastric cancer by inhibiting THBS2.LINC01235-TWIST2 反馈环路通过抑制 THBS2 促进胃癌中的上皮-间充质转化。
Aging (Albany NY). 2020 Nov 18;12(24):25060-25075. doi: 10.18632/aging.103979.
2
Noncoding RNAs in gastric cancer: implications for drug resistance.非编码 RNA 在胃癌中的作用:与耐药性的关系。
Mol Cancer. 2020 Mar 19;19(1):62. doi: 10.1186/s12943-020-01185-7.
3
Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formation.
与白羽肉鸡和木胸肉鸡胸肌中胸宽和蛋白质含量相关的分子途径及关键基因
Front Physiol. 2022 Jul 8;13:936768. doi: 10.3389/fphys.2022.936768. eCollection 2022.
4
Bioinformatics Analysis: The Regulatory Network of hsa_circ_0007843 and hsa_circ_0007331 in Colon Cancer.生物信息学分析:结肠癌中 hsa_circ_0007843 和 hsa_circ_0007331 的调控网络。
Biomed Res Int. 2021 Jul 23;2021:6662897. doi: 10.1155/2021/6662897. eCollection 2021.
原发肿瘤释放富含 ITGBL1 的细胞外囊泡,通过成纤维细胞龛形成促进远端转移瘤生长。
Nat Commun. 2020 Mar 5;11(1):1211. doi: 10.1038/s41467-020-14869-x.
4
EFEMP2 Suppresses the Invasion of Lung Cancer Cells by Inhibiting Epithelial-Mesenchymal Transition (EMT) and Down-Regulating MMPs.EFEMP2通过抑制上皮-间质转化(EMT)和下调基质金属蛋白酶来抑制肺癌细胞的侵袭。
Onco Targets Ther. 2020 Feb 14;13:1375-1396. doi: 10.2147/OTT.S236111. eCollection 2020.
5
The Extracellular Matrix: An Accomplice in Gastric Cancer Development and Progression.细胞外基质:胃癌发生发展的帮凶。
Cells. 2020 Feb 8;9(2):394. doi: 10.3390/cells9020394.
6
Perioperative chemotherapy for gastric cancer in FLOT4.FLOT4研究中胃癌的围手术期化疗
Lancet. 2020 Jan 11;395(10218):e3. doi: 10.1016/S0140-6736(19)32509-7.
7
EFEMP2 Inhibits Breast Cancer Invasion And Metastasis In Vitro And In Vivo.EFEMP2在体外和体内均抑制乳腺癌的侵袭和转移。
Onco Targets Ther. 2019 Oct 30;12:8915-8933. doi: 10.2147/OTT.S221219. eCollection 2019.
8
Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial.腹腔镜辅助与开腹远端胃癌根治术加淋巴结清扫术治疗临床ⅠA 期或ⅠB 期胃癌的生存结局(JCOG0912):一项多中心、非劣效性、Ⅲ期随机对照临床试验。
Lancet Gastroenterol Hepatol. 2020 Feb;5(2):142-151. doi: 10.1016/S2468-1253(19)30332-2. Epub 2019 Nov 19.
9
EFEMP2 suppresses epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in human bladder cancer.EFEMP2 通过 Wnt/β-catenin 信号通路抑制人膀胱癌中的上皮-间质转化。
Int J Biol Sci. 2019 Aug 8;15(10):2139-2155. doi: 10.7150/ijbs.35541. eCollection 2019.
10
Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.对胃腺癌腹膜转移进行的多指标分析鉴定了新的靶点和分子亚型,这些靶点和分子亚型可预测治疗反应。
Gut. 2020 Jan;69(1):18-31. doi: 10.1136/gutjnl-2018-318070. Epub 2019 Jun 6.